Corcept Therapeutics Incorporated - PE Ratio

The PE Ratio as of June 2026 (TTM) for Corcept Therapeutics Incorporated (CORT) is 228.31

According to Corcept Therapeutics Incorporated’s latest financial reports and current stock price. The company's current PE Ratio is 228.31. This represents a change of 439.75% compared to the average of 42.30 of the last 4 quarters.

Corcept Therapeutics Incorporated (CORT) Historical PE Ratio (quarterly & annually)

How has CORT PE Ratio performed in the past?

The mean historical PE Ratio of Corcept Therapeutics Incorporated over the last ten years is 33.26. The current 228.31 PE Ratio has changed 68.54% with respect to the historical average. Over the past ten years (40 quarters), CORT's PE Ratio was at its highest in in the March 2025 quarter at 150.29. The PE Ratio was at its lowest in in the March 2026 quarter at -33.59.

Corcept Therapeutics Incorporated (CORT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Corcept Therapeutics Incorporated PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Corcept Therapeutics Incorporated (CORT) Average PE Ratio

How has CORT PE Ratio performed in the past?

The current PE Ratio of Corcept Therapeutics Incorporated (CORT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Corcept Therapeutics Incorporated (CORT) PE Ratio vs. Peers

How is CORT’s PE Ratio compared to its peers?

Corcept Therapeutics Incorporated’s PE Ratio is greater than Halozyme Therapeutics, Inc. (23.48), greater than Abivax S.A. (-17.61), greater than Rhythm Pharmaceuticals, Inc. (-30.92), greater than Merus N.V. (-19.52), greater than Cytokinetics, Incorporated (-11.53), less than Jazz Pharmaceuticals plc (547.95), greater than Caris Life Sciences, Inc. (-11.87), greater than Axsome Therapeutics, Inc. (-67.16), greater than Nuvalent, Inc. (-20.37), greater than Atrium Therapeutics, Inc. (-4.74),

Build a custom stock screener for Corcept Therapeutics Incorporated (CORT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corcept Therapeutics Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Corcept Therapeutics Incorporated (CORT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Corcept Therapeutics Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.